Inhibition of lipolysis may contribute to the acute regulation of plasma FFA and glucose by FGF21 in ob/ob mice (Q38350544)

2 September 2017

Inhibition of lipolysis may contribute to the acute regulation of plasma FFA and glucose by FGF21 in ob/ob mice (English)

1 reference

2 September 2017

0 references

Xiaofan Li

1

1 reference

2 September 2017

Hongfei Ge

2

1 reference

2 September 2017

Jennifer Weiszmann

3

1 reference

2 September 2017

Randy Hecht

4

1 reference

2 September 2017

Yue-sheng Li

5

1 reference

2 September 2017

Murielle M Véniant

6

1 reference

2 September 2017

Jing Xu

7

1 reference

2 September 2017

Xinle Wu

8

1 reference

2 September 2017

Richard Lindberg

9

1 reference

2 September 2017

Yang Li

10

1 reference

2 September 2017

language of work or name

English

0 references

publication date

12 September 2009

1 reference

2 September 2017

1 reference

2 September 2017

583

1 reference

2 September 2017

19

1 reference

2 September 2017

3230-3234

1 reference

FGF-21 as a novel metabolic regulator

2 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.09.012

Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.09.012

Fibroblast growth factor 21 corrects obesity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.09.012

The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.09.012

BetaKlotho is required for metabolic activity of fibroblast growth factor 21

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.09.012

betaKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.09.012

FGF-21/FGF-21 receptor interaction and activation is determined by betaKlotho

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.09.012

Activation of G protein-coupled receptor 43 in adipocytes leads to inhibition of lipolysis and suppression of plasma free fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.09.012

Selective activation of FGFR4 by an FGF19 variant does not improve glucose metabolism in ob/ob mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.09.012

Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.09.012

FGF21 attenuates lipolysis in human adipocytes - a possible link to improved insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.09.012

Effects of free fatty acids on gluconeogenesis and autoregulation of glucose production in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.09.012

Insulin resistance in type 2 diabetes: role of fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.09.012

Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.09.012

10.1016/J.FEBSLET.2009.09.012

21 January 2018

Identifiers

DOI

1 reference

2 September 2017

1 reference